Continuum Advisory’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-455
| Closed | -$33K | – | 765 |
|
|
2025
Q1 | $33K | Sell |
455
-47
| -9% | -$3.41K | ﹤0.01% | 764 |
|
|
2024
Q4 | $37.2K | Sell |
502
-153
| -23% | -$11.3K | ﹤0.01% | 723 |
|
|
2024
Q3 | $43.3K | Sell |
655
-69
| -10% | -$4.57K | 0.01% | 684 |
|
|
2024
Q2 | $66.9K | Buy |
724
+2
| +0.3% | +$185 | 0.01% | 564 |
|
|
2024
Q1 | $63.1K | Buy |
+722
| New | +$63.1K | 0.01% | 565 |
|
|
2023
Q4 | – | Sell |
-5,560
| Closed | -$385K | – | 460 |
|
|
2023
Q3 | $385K | Sell |
5,560
-594
| -10% | -$41.2K | 0.06% | 320 |
|
|
2023
Q2 | $581K | Buy |
6,154
+76
| +1% | +$7.17K | 0.09% | 259 |
|
|
2023
Q1 | $503K | Sell |
6,078
-45
| -0.7% | -$3.72K | 0.09% | 264 |
|
|
2022
Q4 | $457K | Sell |
6,123
-164
| -3% | -$12.2K | 0.08% | 273 |
|
|
2022
Q3 | $519K | Sell |
6,287
-418
| -6% | -$34.5K | 0.09% | 228 |
|
|
2022
Q2 | $638K | Sell |
6,705
-13
| -0.2% | -$1.24K | 0.12% | 215 |
|
|
2022
Q1 | $711K | Sell |
6,718
-317
| -5% | -$33.6K | 0.14% | 190 |
|
|
2021
Q4 | $911K | Sell |
7,035
-50
| -0.7% | -$6.48K | 0.2% | 114 |
|
|
2021
Q3 | $802K | Sell |
7,085
-76
| -1% | -$8.6K | 0.21% | 110 |
|
|
2021
Q2 | $742K | Buy |
+7,161
| New | +$742K | 0.23% | 103 |
|